how common is gastroparesis with semaglutide and Ozempic: Understanding Stomach Paralysis Wegovy Lawsuit Over Gastroparesis |

Do not discontinue semaglutide without medical guidance

Bridge program Medicare GLP-1 Bridge: $50/month for eligible Medicare Advantage beneficiaries from July 1, 2026 through December 31, 2027

It does not have to be

This mode of action confirms what the experts have been saying for several years, namely that it is a reduction in calorie intake that remains the main means of losing weight (physical exercise has enormous health benefits, but does not have major effects on weight loss)

The European Medicines Agency concluded that the benefits of Ozempic seen in studies outweighed its risk and recommended it be approved for use in the EU

There are other studies looking at the potential benefits of semaglutide for several other conditions - we will post those soon